HOME Research Insight Expansions was a Key Strategy Adopted by Major Players to Achieve Growth in the Global Pyridine & Pyridine Derivatives Market Between 2014 and 2016

Expansions was a Key Strategy Adopted by Major Players to Achieve Growth in the Global Pyridine & Pyridine Derivatives Market Between 2014 and 2016

The pyridine & pyridine derivatives market is projected to reach USD 656.3 Million by 2021, at a CAGR of 6.6% from 2016 to 2021. Pyridine, is a colorless liquid which is flammable and has an unpleasant smell. There is a growing demand for pyridine from various applications such as agrochemicals, pharmaceuticals, latexes, and others.

Expansions was a key strategy adopted by major players to achieve growth in the global pyridine & pyridine derivatives market between 2014 and 2016. Some of the major players in the pyridine & pyridine derivatives market are Jubilant Life Sciences Ltd. (India), Vertellus Holdings LLC (U.S.), Lonza Group AG (Switzerland), Nanjing Redsun Co. Ltd. (China), Resonance Specialties Ltd. (India), Shandong Luba Chemical Co. Ltd. (China), Hubei Sanonda Co. Ltd. (China), Chang Chun Petrochemical Co. Ltd. (Taiwan), Koei Chemical Co. Ltd. (Japan), and C-Chem Co., Ltd. (Japan). Besides expansions, companies also adopted new product developments, mergers & acquisitions, joint-ventures, and agreements strategies to expand their product portfolios, strengthen their distribution networks, and extend their reach to customers.

Vertellus is the global market leader in the manufacture of pyridine and picoline and the world’s number two producer of vitamin B3. The company has fully-integrated facilities that cater across the pyridine chemistry value chain, and has 10 manufacturing facilities around the globe, including facilities in the U.S., Europe, China, and India. Vertellus Holdings LLC used expansions as its major strategy to increase its regional reach and market share in the pyridine & pyridine derivatives market. In May 2014, Vertellus expanded its production capacity, to serve customers around the globe.  The expansion plans included increase in production capacity at the Indianapolis manufacturing plant and the addition of vitamin B3 production capacity at the Nantong site.

Lonza Group AG has a comprehensive pyridine and pyridine based product portfolio that caters to the demand from major end users. The company has several patents with respect to pyridine, and there is much scope for enhancing its product portfolio. Core competencies of the company are advanced manufacturing and quality-control systems, superior regulatory expertise, in-depth market knowledge, and extensive technical customer support, and R&D capabilities.

The company adopted mergers and acquisitions as its major strategy to increase production and cater to the rising demand for pyridine & pyridine derivatives. In 2016, Lonza acquired InterHealth Nutraceuticals, Inc. a U.S. based company which deals with research, development, manufacture, and marketing of value-added nutritional ingredients for use in dietary supplements.

Related Reports:

Pyridine & Pyridine Derivatives Market by Type (Pyridine, Beta Picoline, Alpha Picoline, Gamma Picoline), Application (Agrochemicals, Pharmaceuticals, Latexes, Food), Region (North America, Europe, Asia Pacific) - Global Forecast to 2021

Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports